The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or within a few hours (delayed pneumothorax). The incidence of pneumothorax in the literature is very different from one study to another: it has been reported to be from 9 to 54% in patients undergoing percutaneous transthoracic needle biopsy. This difference of incidence could be explained by the absence of consensus for the definition of an iatrogenic pneumothorax. The characteristics of pneumothorax and the management of patients with iatrogenic pneumothorax will be evaluated in different centres in a retrospective manner. This study will contribute to refining the criteria for defining pneumothorax occurring during lung biopsy and will provide a better understanding of the condition and its management.
Study Type
OBSERVATIONAL
Enrollment
243
This is a retrospective study. No intervention.
CHU de Besançon
Besançon, France
Institut Bergonié
Bordeaux, France
CHU de Tours
Tours, France
Institut Gustave Roussy
Villejuif, France
Saint James Hospital
Dublin, Ireland
Oxford University Hospitals
Oxford, United Kingdom
Annual incidence rate of pneumothorax related to transthoracic lung biopsy on total number of lung biopsies
Time frame: 3 months
Annual incidence rate of hospitalisation in patients with pneumothorax related to lung biopsies
Time frame: 3 months
Annual incidence rate of drainage in patients with pneumothorax related to lung biopsies
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.